Ranchoff Brittany L, Jeung Chanup, Zeber John E, Simon Gregory E, Ericson Keith M, Qian Jing, Geissler Kimberley H
School of Public Health and Health Sciences, University of Massachusetts Amherst, Amherst, MA, USA.
School of Public Health, State University of New York at Albany, Albany, NY, USA.
Schizophrenia (Heidelb). 2024 Feb 26;10(1):25. doi: 10.1038/s41537-024-00446-4.
Changes in health insurance coverage may disrupt access to and continuity of care, even for those who remain insured. Continuity of care is especially important in schizophrenia, which requires ongoing medical and pharmaceutical treatment. However, little is known about continuity of insurance coverage among those with schizophrenia. The objective was to examine the probability of insurance transitions for individuals with schizophrenia who were continuously insured and whether this varied across insurance types. The Massachusetts All-Payer Claims Database identified individuals with schizophrenia aged 18-64 who were continuously insured during a two-year period between 2014 and 2018. A logistic regression estimated the association of having an insurance transition - defined as having a change in insurance type - with insurance type at the start of the period, adjusting for age, sex, ZIP code in the lowest quartile of median income, and ZIP code with concentrated poverty. Overall, 15.1% had at least one insurance transition across a 24-month period. Insurance transitions were most frequent among those with plans from the Marketplace. In regression adjusted results, individuals covered by the traditional Medicaid program were 20.2 percentage points [pp] (95% confidence interval [CI]: 24.6 pp, 15.9 pp) less likely to have an insurance transition than those who were insured by a Marketplace plan. Insurance transitions among individuals with schizophrenia were common, with more than one in six people having at least one transition in insurance type during a two-year period. Given that even continuously insured individuals with schizophrenia commonly experience insurance transitions, attention to insurance transitions as a barrier to care access and continuity is warranted.
医疗保险覆盖范围的变化可能会扰乱医疗服务的获取和连续性,即使是那些仍有保险的人。连续性护理在精神分裂症中尤为重要,因为该病需要持续的药物和医疗治疗。然而,对于精神分裂症患者的保险覆盖连续性知之甚少。本研究的目的是检验持续参保的精神分裂症患者发生保险转换的概率,以及这种概率是否因保险类型而异。马萨诸塞州全支付方索赔数据库识别出了年龄在18 - 64岁之间、在2014年至2018年的两年期间持续参保的精神分裂症患者。逻辑回归分析估计了发生保险转换(定义为保险类型发生变化)与该时期开始时的保险类型之间的关联,并对年龄、性别、收入中位数最低四分位数的邮政编码以及贫困集中地区的邮政编码进行了调整。总体而言,15.1%的人在24个月内至少有一次保险转换。在通过市场计划参保的人群中,保险转换最为频繁。在回归调整后的结果中,参加传统医疗补助计划的个体发生保险转换的可能性比通过市场计划参保的个体低20.2个百分点[pp](95%置信区间[CI]:24.6 pp,15.9 pp)。精神分裂症患者中的保险转换很常见,超过六分之一的人在两年内至少有一次保险类型转换。鉴于即使是持续参保的精神分裂症患者也普遍经历保险转换,因此有必要关注保险转换作为医疗服务获取和连续性障碍的问题。